Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 249, Issue 8, 2011, Pages 1235-1243

  Doycheva, Deshka ^a   Zierhut, Manfred ^a   Blumenstock, Gunnar ^b   Stuebiger, Nicole ^a,c   Deuter, Christoph ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Efficacy; Immunosuppressive treatment; Mycophenolate mofetil; Side effects; Uveitis

Indexed keywords

ADALIMUMAB; ALPHA INTERFERON; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDIASIS; CHILD; CHRONIC NONINFECTIOUS UVEITIS; CONTROLLED STUDY; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; EYE INFLAMMATION; FATIGUE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GINGIVITIS; HAIR LOSS; HERPES SIMPLEX; HUMAN; INFLAMMATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MYALGIA; MYCOSIS; PRIORITY JOURNAL; PYELONEPHRITIS; RASH; RELAPSE; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT DURATION; TREATMENT OUTCOME; UVEITIS; VIRAL SKIN DISEASE; VISUAL ACUITY;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY; YOUNG ADULT;

EID: 80052774161     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-011-1731-8     Document Type: Article

References (24)

1. OM Durrani CA Meads PI Murray 2004 Uveitis: a potentially blinding disease Ophthalmologica 218 223 236 15258410 10.1159/000078612 1:STN:280:DC%2BD2czlsFOjtA%3D%3D (Pubitemid 38969828)
2. DA Jabs JT Rosenbaum CS Foster GN Holland GJ Jaffe JS Louie RB Nussenblatt ER Stiehm H Tessler RN Van Gelder SM Whitcup D Yocum 2000 Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel Am J Ophthalmol 130 492 513 11024423 10.1016/S0002-9394(00)00659-0 1:CAS:528:DC%2BD3cXnt1Shsrc%3D
3. K Greiner M Varikkara C Santiago JV Forrester 2002 Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis Ophthalmologe 99 691 694 12219257 10.1007/s00347-002-0651-8 1:STN:280: DC%2BD38vmtVWksw%3D%3D (Pubitemid 36358254)
4. S Baltatzis F Tufail EN Yu CM Vredeveld CS Foster 2003 Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders Ophthalmology 110 1061 1065 12750115 10.1016/S0161- 6420(03)00092-7 (Pubitemid 36560514)
5. JE Thorne DA Jabs FA Qazi QD Nguyen JH Kempen JP Dunn 2005 Mycophenolate mofetil therapy for inflammatory eye disease Ophthalmology 112 1472 1477 16061096 10.1016/j.ophtha.2005.02.020 (Pubitemid 41074642)
6. K Siepmann M Huber N Stuebiger C Deuter M Zierhut 2006 Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis: a retrospective analysis of 106 patients Graefes Arch Clin Exp Ophthalmol 244 788 794 16163494 10.1007/s00417-005-0066-8 1:CAS:528: DC%2BD28XntVSms7g%3D (Pubitemid 44103323)
7. SC Teoh AC Hogan AD Dick RW Lee 2008 Mycophenolate mofetil for the treatment of uveitis Am J Ophthalmol 146 752 760 18455143 10.1016/j.ajo.2008.03. 004 1:CAS:528:DC%2BD1cXhtlWrsrrE
8. E Daniel JE Thorne CW Newcomb SS Pujariss RO Kacmaz GA Levy-Clarke RB Nussenblatt JT Rosenbaum EB Suhler CS Foster D Jabs JH Kempen 2010 Mycophenolate mofetil for ocular inflammation Am J Ophthalmol 149 423 432 20042178 10.1016/j.ajo.2009.09.026 1:CAS:528:DC%2BC3cXit1ags7c%3D
9. AC Allison 2005 Mechanisms of action of mycophenolate mofetil Lupus 14 2 8 10.1191/0961203305lu2109oa
10. AC Allison EM Eugui 2000 Mycophenolate mofetil and its mechanisms of action Immunopharmacology 47 85 118 10878285 10.1016/S0162-3109(00)00188-0 1:CAS:528:DC%2BD3cXktlKkt7o%3D (Pubitemid 30394534)
11. A Galor DA Jabs HA Leder SR Kedhar JP Dunn GB Peters 3rd JE Thorne 2008 Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation Ophthalmology 115 1826 1832 18579209 10.1016/j.ophtha.2008.04.026
12. JH Kempen S Gangaputra E Daniel GA Levy-Clarke RB Nussenblatt JT Rosenbaum EB Suhler JE Thorne CS Foster DA Jabs KJ Helzlsouer 2008 Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence Am J Ophthalmol 146 802 812 18579112 10.1016/j.ajo.2008.04.035 1:CAS:528:DC%2BD1cXhsVWhtLjP
13. JH Kempen E Daniel JP Dunn CS Foster S Gangaputra A Hanish KJ Helzlsouer DA Jabs RO Kacmaz GA Levy-Clarke TL Liesegang CN Newcomb RB Nussenblatt SS Pujariss JT Rosenbaum EB Suhler JE Thorne 2009 Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study BMJ 339 b2480 19578087 10.1136/bmj.b2480
14. DJ Kilmartin JV Forrester AD Dick 1998 Rescue therapy with mycophenolate mofetil in refractory uveitis Lancet 352 35 36 9800750 10.1016/S0140-6736(05) 79515-5 1:STN:280:DyaK1M%2FhsFenug%3D%3D (Pubitemid 28306570)
15. G Larkin S Lightman 1999 Mycophenolate mofetil a useful immunosuppressive in inflammatory eye disease Ophthalmology 106 370 374 9951492 10.1016/S0161-6420(99)90078-7 1:STN:280:DyaK1M7js1KnsQ%3D%3D (Pubitemid 30191639)
16. CH Lau M Comer S Lightman 2003 Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation Clin Experiment Ophthalmol 31 487 491 14641155 10.1046/j.1442-9071.2003.00704.x (Pubitemid 38049225)
17. D Doycheva C Deuter N Stuebiger S Biester M Zierhut 2007 Mycophenolate mofetil in the treatment of uveitis in children Br J Ophthalmol 91 180 184 16825275 10.1136/bjo.2006.094698 1:STN:280:DC%2BD2s%2FktlWrtw%3D%3D (Pubitemid 46202865)
18. E Bloch Michel RB Nussenblatt 1987 International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease Am J Ophthalmol 103 234 235 3812627 1:STN:280:DyaL2s7isFSlsw%3D%3D
19. DA Jabs RB Nussenblatt JT Rosenbaum 2005 Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop Am J Ophthalmol 140 509 516 16196117 10.1016/j.ajo.2005.03.057 (Pubitemid 41224845)
20. F Buttgereit JAP da Silva M Boers GR Burmester M Cutolo J Jacobs J Kirwan L Köhler P van Riel T Vischer JWJ Bijlsma 2002 Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology Ann Rheum Dis 61 718 722 12117678 10.1136/ard.61.8.718 1:CAS:528:DC%2BD38XmsVajuro%3D (Pubitemid 34787710)
21. L Sobrin W Christen CS Foster 2008 Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis Ophthalmology 115 1416 1421 18221998 10.1016/j.ophtha.2007.12.011
22. P Bhat RE Cervantes-Castaneda PP Doctor F Auzaar CS Foster 2009 Mycophenolate mofetil therapy for sarcoidosis-associated uveitis Ocul Immunol Inflamm 17 185 190 19585361 10.1080/09273940902862992 1:CAS:528: DC%2BD1MXosVWmu7k%3D
23. CME Deuter D Doycheva N Stuebiger M Zierhut 2009 Mycophenolate sodium for immunosuppressive treatment in uveitis Ocul Immunol Inflamm 17 415 419 20001262 10.3109/09273940903137675 1:CAS:528:DC%2BD1MXhsFCiurvN
24. U Pleyer P Ruokonen N Schnidt E Feist M Höhne S Stanojlovic 2008 Mycophenolic acid in ocular autoimmune disorders - can we optimise this therapy? Klin Monbl Augenheilkd 225 66 69 18236373 10.1055/s-2008-1027134 1:STN:280:DC%2BD1c%2FnvVCksQ%3D%3D (Pubitemid 351251519)